Showing results (1701-1710 of 9,422) with videos related to

Sort By:
Pageof 943
Clinical Endocrinology|December 1, 1991
Effects of ambient glycaemic state on growth hormone responsiveness in insulin-dependent diabetesI S Ismail, M F Scanlon, J R Peters
Clinical Endocrinology|August 19, 2007
Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infectionGiuseppe Indolfi, Stefano Stagi, Elisa Bartolini, et al.
Clinical Endocrinology|August 19, 2007
Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancerFrances Dockery, Christopher J Bulpitt, Sanjiv Agarwal, et al.
Clinical Endocrinology|June 19, 2007
Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapyAnnamaria Colao, Antonella Di Sarno, Ermelinda Guerra, et al.
Clinical Endocrinology|August 31, 2007
Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiencyMikkel Andreassen, Henrik Vestergaard, Lars Østergaard Kristensen
Clinical Endocrinology|June 15, 2007
Predictors of late menarche and adult height in children with anorexia nervosaCatherine Rozé, Catherine Doyen, Marie-France Le Heuzey, et al.
Clinical Endocrinology|June 15, 2007
Parity, pregnancy and neonatal outcomes in women treated for hyperprolactinaemia compared with a control groupKatarina Berinder, Anna-Lena Hulting, Fredrik Granath, et al.
Clinical Endocrinology|December 20, 2008
No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjectsSusanne Lerche, Liselotte Soendergaard, Joergen Rungby, et al.
Clinical Endocrinology|December 20, 2008
Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?Gustavo Mafaldo Soares, Carolina Sales Vieira, Wellington Paula Martins, et al.
Clinical Endocrinology|December 20, 2008
Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegalyAnnamaria Colao, Renata S Auriemma, Alberto Rebora, et al.
Pageof 943